Selective placental transport of maternal IgG to the fetus

doi:10.1016/0143-4004(95)90018-7

Placenta

Volume 16, Issue 8, December 1995, Pages 749-756

https://doi.org/10.1016/0143-4004(95)90018-7 Get rights and content

Abstract

During pregnancy there is a dramatic reduction in the serum levels of agalactosyl IgG (G0IgG) in both normal women and those with rheumatoid arthritis. In order to determine if a similar reduction in G0IgG were apparent in fetal serum, a comparison of the galactose content of IgG from nine paired samples of umbilical vein or fetal blood and peripheral maternal serum, at gestational ages ranging from 16–41 weeks was performed. The full-term maternal IgG samples were highly galactosylated, so confirming previous observations of reduced G0IgG levels during pregnancy. In addition every paired sample of fetal IgG had a higher level of galactosylation than the corresponding maternal IgG. Therefore, during pregnancy there is both a reduced biosynthesis of the G0IgG glycoform by the mother, and a restriction of its transport across the placenta. The ratio of estimated G0IgG in fetal and maternal serum was found to be related to changes in IgG transport, and in particular the active transport of IgG₁ across the placenta during gestation. Our data suggest that the placental IgG transport mechanism is either carbohydrate independent by discriminating for IgG₁, or is carbohydrate dependent selecting for highly galactosylated IgG glycoforms. This study emphasizes the need for further investigations on the biological function of G0IgG in normal physiological states, in addition to disease states, such as juvenile and adult rheumatoid arthritis, where elevated G0IgG levels correlate with disease activity.

References (18)

C.M. Black et al.
Two-site immunoenzymometric assay for serum IgG subclass infant/maternal ratios at full term
Journal of Immunological Methods
(1988)
S.M. Hobbs et al.
Interaction of aglycosyl IgG with the IgG Fc transport receptor from neonatal rat gut: comparison of deglycosylation by tunicamycin treatment and genetic engineering
Molecular Immunology
(1992)
R.B. Parekh et al.
Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis in relation to disease
Lancet
(1988)
R.B. Parekh et al.
A comparative analysis of disease-associated changes in the galactosylation of serum IgG
Journal of Autoimmunity
(1989)
G.A.W. Rook et al.
Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy
Journal of Autoimmunity
(1991)
C.Y. Yeung et al.
Serum IgG levels in normal, premature, post-mature and small for dates newborn babies
Lancet
(1968)
D. Ashford et al.
The β1-2-d-xylose and α1-3-l-fucose substituted N-linked oligosaccharides from Erythrina cristagalli lectin
European Journal of Biochemistry
(1987)
W.P. Burmeister et al.
Crystal structure at 2.2A resolution of the MHC-related neonatal Fc receptor
Nature
(1994)
W.P. Burmeister et al.
Crystal structure of the complex of rat neonatal Fc receptor with Fc
Nature
(1994)

There are more references available in the full text version of this article.

Cited by (43)

Are high avidity antibodies to Plasmodium falciparum antigens preferentially transferred across the placenta of premature and term babies?
2023, Placenta
Transplacental transport of maternal IgG via the neonatal Fc receptor (FcRn) provides babies with passive immunity. Several factors are reported to influence transport, including the avidity of antibodies (Abs) for their cognate antigens. Unfortunately, information on the role of antibody (Ab) avidity is limited. This study investigated if i) antibodies (Abs) with high avidity for 6 Plasmodium falciparum antigens and tetanus toxoid (TTx) were preferentially transferred to premature and term Cameroonian babies and ii) if Ab avidity was increased in babies whose mothers had placental malaria (PM), implicating the involvement of immune complexes.
Total IgG (mg/ml) and Abs to malarial antigens (AMA1, EBA-175, MSP1-42, MSP2, MSP3, DBL5 of VAR2CSA) and TTx were measured in paired mother-cord samples obtained from premature and term deliveries in Cameroon. Half the women had PM at delivery. Avidity Indices (AIs) were determined by treating antigen-bound-Abs with different molar concentrations of NH₄SCN and calculating 50% endpoints.
Total IgG and antigen-specific Abs increased in cord blood with gestational age; however, AIs did not. AIs in paired maternal-cord blood samples were strongly associated for all antigens (r = 0.77–0.96). However, no significant different in AIs was found between paired mother-cord blood samples for any of the antigens (p values > 0.05). Similarly, Ab avidity was not increased in cord blood of babies whose mothers had PM or hypergammaglobulinemia.
Overall, there was no evidence that higher avidity Abs to any of the malarial antigens or TTx were preferentially transferred to Cameroonian babies.
Contribution of the ex vivo placental perfusion model in understanding transplacental immunoglobulin G transfer
2022, Placenta
Citation Excerpt :
It has been instrumental for our understanding that FcγRs do not contribute the transfer of IgG across human placenta to the same degree as FcRn [24,57–61]. Rather, such receptors may modulate the transfer [59,65–67]. The current understanding of the process of antibody transplacental transport has so far resulted in clinical trials to treat alloimmune mediated pregnancy complications with nipocalimab, which is promising for the treatment of hemolytic diseases.
The acquisition of humoral immunity in utero is essential for the fetus. The crucial protein, which is responsible for this part of immunity, is immunoglobulin-G (IgG). Immune functions of IgGs are mediated via the interaction of the crystallizable fragment (Fc) region of IgG with specific Fc γ receptors (FcγRs). However, an atypical FcγR, the neonatal Fc receptor (FcRn), is a key regulator of IgG transfer across the human placenta. During the last four decades ex vivo placental perfusion studies have contributed significantly to the study of mechanisms of IgG transfer across the multicellular placental barrier.
A PubMed search was conducted by using specific keywords: placenta, perfusion and IgG to review manuscripts using human placental perfusion to study the transplacental transfer of IgG. Relevant studies found in reference lists of these manuscripts were also added to the review, and references were included that supported or gave nuance to the discussion of the mechanisms of IgG kinetics in the placenta.
We found twenty publications on the study of transplacental transfer of IgG using human ex vivo placental perfusion, by research groups with partly different settings. This review summarizes knowledge about placental IgG transfer, with a strong focus on the contributions from ex vivo placental perfusion studies.
Human IgG Glycosylation in Inflammation and Inflammatory Disease
2021, Comprehensive Glycoscience: Second Edition
Inflammation is a defense mechanism that is initiated to protect complex multi-cellular organisms from infection by parasites; e.g. bacteria, virus etc., effecting their inactivation and elimination. This aggressive activity must be tightly controlled in order to avoid damage to bystander (self) tissue. On infection immediate protection may be afforded by inflammatory mechanisms triggered by the innate immune response, which, in turn, initiates an adaptive humoral (antibody) and cellular response. A mature (secondary) protective antibody response is characterized by the quantitative predominance of antibodies of the IgG class in blood and extra-vascular fluids. Four subclasses of IgG are defined and each has been shown to exhibit a unique profile of abilities to activate inflammatory pathways, in vitro. It is established that glycosylation of IgG is essential to the activation of these inflammatory pathways and that normal polyclonal IgG is heterogeneous with respect to the precise structure of the oligosaccharides attached to individual molecules. Importantly, it has been shown that the glycoform profile of an antibody response can influence the inflammatory pathways activated. The glycoform profile of polyclonal IgG is altered in a number of diseases that are characterized as “inflammatory” and within IgG antibody responses to individual antigens. It is essential, therefore, to elucidate the consequences for the inflammatory cascades activated and their role in resolution of disease.
Maternal immunisation: collaborating with mother nature
2017, The Lancet Infectious Diseases
Citation Excerpt :
Two studies79,80 have suggested that high avidity antibodies can be transferred preferentially across the placenta. Previously, studies also suggested a preferential transfer of hypergalactosylated IgG, but this theory was not supported by a more recent study that used more advanced technologies, which showed that Fc galactosylation had no effect on IgG transfer.81,82 Chronic maternal infections and hypergammaglobulinaemia have a profound effect on maternal antibody transfer.69
Maternal immunisation has the potential to substantially reduce morbidity and mortality from infectious diseases after birth. The success of tetanus, influenza, and pertussis immunisation during pregnancy has led to consideration of additional maternal immunisation strategies to prevent group B streptococcus and respiratory syncytial virus infections, among others. However, many gaps in knowledge regarding the immunobiology of maternal immunisation prevent the optimal design and application of this successful public health intervention. Therefore, we did an innovative landscape analysis to identify research priorities. Key topics were delineated through review of the published literature, consultation with vaccine developers and regulatory agencies, and a collaborative workshop that gathered experts across several maternal immunisation initiatives—group B streptococcus, respiratory syncytial virus, pertussis, and influenza. Finally, a global online survey prioritised the identified knowledge gaps on the basis of expert opinion about their importance and relevance. Here we present the results of this worldwide landscape analysis and discuss the identified research gaps.
Passively Acquired Antibody-Dependent Cellular Cytotoxicity (ADCC) activity in HIV-infected infants is associated with reduced mortality
2015, Cell Host and Microbe
Citation Excerpt :
A more intriguing possibility is that the differences between maternal and infant ADCC are due to differences in passive transfer of antibodies to the infants. IgG subclass and the glycosylation profile of antibodies impact ADCC activity and have also been suggested to be differentially transferred across the placenta (Ackerman et al., 2013; Ferrante et al., 1990; Hashira et al., 2000; Simister, 2003; Williams et al., 1995; Wren et al., 2013), suggesting that maternal ADCC antibody levels may not always be indicative of infant repertoires. In any case, these results have important implications given that prior studies often focused on the relationship between maternal antibody responses, rather than infant responses, and protection.
In addition to direct effects on virus infectivity, antibodies mediate antibody-dependent cellular cytotoxicity (ADCC), the killing of an antibody-coated virus-infected cell by cytotoxic effector cells. Although ADCC has been suggested to protect against HIV, the relationship between HIV-specific ADCC antibodies at the time of HIV exposure and infection outcome in humans remains to be assessed. We evaluated the ADCC activity of passively acquired antibodies in infants born to HIV-infected mothers. ADCC levels were higher in uninfected than infected infants, although not significantly. Increase in ADCC antibody activity in infected infants was associated with reduced mortality risk. Infant ADCC positively correlated with the magnitude of IgG1 binding, and IgG1 levels were associated with survival in infected infants. Infant IgG3-binding antibodies were not associated with infected infant survival. These data suggest a therapeutic benefit of pre-existing HIV-specific ADCC antibodies and support a role for eliciting ADCC-mediating IgG1 in HIV vaccines.
N-glycomic biomarkers of biological aging and longevity: A link with inflammaging
2013, Ageing Research Reviews
Citation Excerpt :
Moreover, the level of galactosylation was much lower among ACPA than in IgG repertoire (Ercan et al., 2010). Galactosylation could influence the placental transport of antibodies, in that the level of IgG-G0 is always lower in the fetus than in its mother (Williams et al., 1995; Kibe et al., 1996). Nevertheless, IgG-G0 antibodies appear to be involved in the transmission from mother to child of autoimmune diseases, such as systemic lupus erythematosus (SLE) (Pilkington et al., 1996b) and myastenia gravis (Pilkington et al., 1995a).
Glycosylation is a frequent co/post-translational modification of proteins which modulates a variety of biological functions. The analysis of N-glycome, i.e. the sugar chains N-linked to asparagine, identified new candidate biomarkers of aging such as N-glycans devoid of galactose residues on their branches, in a variety of human and experimental model systems, such as healthy old people, centenarians and their offspring and caloric restricted mice. These agalactosylated biantennary structures mainly decorate Asn297 of Fc portion of IgG (IgG-G0), and are present also in patients affected by progeroid syndromes and a variety of autoimmune/inflammatory diseases. IgG-G0 exert a pro-inflammatory effect through different mechanisms, including the lectin pathway of complement, binding to Fcγ receptors and formation of autoantibody aggregates. The age-related accumulation of IgG-G0 can contribute to inflammaging, the low-grade pro-inflammatory status that characterizes elderly, by creating a vicious loop in which inflammation is responsible for the production of aberrantly glycosylated IgG which, in turn, would activate the immune system, exacerbating inflammation. Moreover, recent data suggest that the N-glycomic shift observed in aging could be related not only to inflammation but also to alteration of important metabolic pathways. Thus, altered N-glycans are both powerful markers of aging and possible contributors to its pathogenesis.

View all citing articles on Scopus

View full text

Article preview

Placenta

Abstract

References (18)

Two-site immunoenzymometric assay for serum IgG subclass infant/maternal ratios at full term

Journal of Immunological Methods

Interaction of aglycosyl IgG with the IgG Fc transport receptor from neonatal rat gut: comparison of deglycosylation by tunicamycin treatment and genetic engineering

Molecular Immunology

Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis in relation to disease

Lancet

A comparative analysis of disease-associated changes in the galactosylation of serum IgG

Journal of Autoimmunity

Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy

Journal of Autoimmunity

Serum IgG levels in normal, premature, post-mature and small for dates newborn babies

Lancet

The β1-2-d-xylose and α1-3-l-fucose substituted N-linked oligosaccharides from Erythrina cristagalli lectin

European Journal of Biochemistry

Crystal structure at 2.2A resolution of the MHC-related neonatal Fc receptor

Nature

Crystal structure of the complex of rat neonatal Fc receptor with Fc

Nature

Cited by (43)

Are high avidity antibodies to Plasmodium falciparum antigens preferentially transferred across the placenta of premature and term babies?

Contribution of the ex vivo placental perfusion model in understanding transplacental immunoglobulin G transfer

Human IgG Glycosylation in Inflammation and Inflammatory Disease

Maternal immunisation: collaborating with mother nature

Passively Acquired Antibody-Dependent Cellular Cytotoxicity (ADCC) activity in HIV-infected infants is associated with reduced mortality

N-glycomic biomarkers of biological aging and longevity: A link with inflammaging

Short communicationSelective placental transport of maternal IgG to the fetus

Abstract

Journal of Immunological Methods

Molecular Immunology

Lancet

Journal of Autoimmunity

Journal of Autoimmunity

Lancet

The β1-2-d-xylose and α1-3-l-fucose substituted N-linked oligosaccharides from Erythrina cristagalli lectin

European Journal of Biochemistry

Crystal structure at 2.2A resolution of the MHC-related neonatal Fc receptor

Nature

Crystal structure of the complex of rat neonatal Fc receptor with Fc

Nature

Short communication
Selective placental transport of maternal IgG to the fetus